Geriatric Drugs and Disease Management Market Trends and Forecast up to 2024

Geriatric Drugs and Disease Management Market: Overview

Geriatric medicine refers to a branch of medicine dealing with the diagnosis, treatment and prevention of diseases in the elderly population. Increasing demand for geriatric care medication and services is attributed to increasing needs of the elderly population. The geriatric population suffers from several ailments such as cerebral disorders, cardiac conditions and other metabolic disorders. As per the data published by the United Nations in the report titled “World Population Ageing” in the year 2013, the global share of the elderly population (aged above 60 years) has increased to 11.7% in the year 2013 as compared to the 9.2% in the year 1990 and is further expected to increase in the future, reaching around 21.1% by 2050. In addition, the geriatric population is expected to be more than 2 billion by 2050.

As per research studies, the prevalence of chronic conditions is increasing among the baby boomer population. For instance, in the United States, around 62% of the elderly population ranging between 50 years to 64 years suffer from one of the six chronic conditions such as diabetes, high cholesterol, arthritis, heart disease and cancer and among the population aged 70 years and above suffer from at least one chronic condition which demands continuous care and management.

Obtain Report Details: http://www.transparencymarketresearch.com/geriatric-drugs-disease-management-market.html

Geriatric Drugs and Disease Management Market: Key Trends and Opportunities

The overall incidence and occurrence of chronic conditions such as diabetes and hypertension is increasing and is further expected to increase with rise in the geriatric population. These chronic conditions and patients’ level of disability in turn influence the medical spending of the respective nations. With the increasing technological advances such as advanced monitoring equipment, innovative surgical techniques and novel drug delivery technologies result in the increasing medical care options to the geriatric population across the globe. As per the data enumerated by the United Nations, it has been estimated that there will around 20% increase observed in the hospital admissions by 2030 as compared to 2004 in the people aged above 65 years.

Hence, all these factors further demand enhanced accessibility to the medications and treatment. ACE inhibitors, aldosterone antagonists, anti-anxiety, vasodilators, anti depressants, anticonvulsants, anti diabetics, diuretics and respiratory agents account for some of the common drugs administered to the geriatric population. Increasing benefits of nutraceuticals promise significant market opportunities with respect to geriatric care. Disease management includes several services such as advanced care planning, nutritional care, socialization programs, sleep management and home care services.

The market for geriatric drugs can be segmented by various drug classes and geriatric care services offered by the service providers. Regulatory and healthcare provisions for the geriatric population announced by the respective nation’s governments govern the market growth.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13046

Geriatric Drugs and Disease Management Market: Regional Dynamics

Geographically, developed regions such as North America and European countries account for the largest market in terms of revenue. This is majorly due to high disposable income of the elderly in these countries followed by favorable reimbursement policies. While Asia Pacific and Rest of the World represent smaller markets as the policies are not standardized and low but increasing disposable incomes of elderly population. The major factors favoring the market growth are innovative medical technologies, novel therapies and enhanced support from the government.

On the other hand, factors such as lack of specialized patient care centers and other hospital units might restrain the market growth. UAS Laboratories, GGNSC Holdings LLC, Senior Care Centers of America along with Geriatric & Medical Companies, Inc., are some of the leading geriatric care service providers.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

 

Bio Surgery Market is Anticipated to Show the Robust Growth During 2016 – 2024

Bio Surgery Market: Overview

Bio-surgery involves a range of surgical techniques that includes natural or synthetic materials to seal surgical incisions; lubricants to enable joint movements; and products that enable tissue repairs. These bio surgery products aid in the process of surgery to minimize intra and post-operative complications. Bio surgery products are also employed to facilitate the hard tissue regeneration in ortho-biologics.

The various bio surgery products available in the market include hemostatic products, sealants, soft tissue repair products, bone graft substitutes, adhesion prevention products, and staple line reinforcement products. The natural bio surgery products comprise allografts, cultured epithelial autografts, and xenografts.

Obtain Report Details: http://www.transparencymarketresearch.com/bio-surgery-market.html

Bio Surgery Market: Segmentation

The bio surgery market can be classified on the basis on product, application, source of the bio surgery product, and geography. Based on the product, the bio surgery market is segmented into sealants (natural sealants, fibrin sealants, surgical sealants and collagen matrix), hemostatic products, adhesion prevention products, soft tissue repair products (surgical mesh, polymeric screens, and repair patches), bone graft substitutes (demineralized bone matrix (DBM), bone morphogenetic proteins (BMP) and synthetic bone graft extenders), and staple line reinforcement products.

The bio surgery market, based on the applications, can be segmented into neurological surgeries, cardiovascular surgeries, orthopedic surgeries, spinal surgeries, thoracic surgeries, gynecologic surgeries, urological surgeries, and reconstruction surgeries. In addition the market can be classified on the basis of the source into natural bio surgery products and synthetic bio surgery products. Based on the geography, the bio surgery market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Bio Surgery Market: Drivers and Challenges

The bio surgery market is mainly driven by increasing number of various surgeries owing to several lifestyle disorders and increasing obesity. In addition, growth in the sports and spine related injuries, aging population are the major drivers for the bio surgery market. Furthermore, the strong focus on research and development (R&D) leading to the launch of various new products into the market and technological advancements (multi-usage products) would significantly contribute to the market growth. However, increasing costs of surgeries, rising demand for minimally invasive or non-invasive surgeries, stringent regulations by various government agencies, and reimbursement policies would negatively impact the bio surgery market. In addition, the non-acceptance of certain products such as human tissue for regenerative purposes due to ethical concerns in certain parts of the world such as Europe might impact product sales in the bio surgery market.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12956

Sealants and the hemostatic products are the widely employed bio surgery products in the market. In terms of geography, North America had the largest share in the bio surgery market followed by Europe due to the increasing obesity related surgeries and other spinal and sports related surgeries. However, the growth is expected to be stagnant in the North American regions and weak in the Euro zone countries. The emerging markets in Asia Pacific, Latin America and the Middle East and Africa are expected to record strong growth during the forecast period due to the increase in the investments by the private and public players in these countries, growing healthcare industry, and increase in the aging population leading to the growth in the patient population in these countries. India, China and Brazil are expected to drive strong growth among the emerging countries, owing to the increasing investments by the government to enhance the healthcare facilities.

Bio Surgery Market: Key Players

The leading players in the bio surgery market include Baxter International Inc., C.R. Bard (Davol), Johnson & Johnson (Ethicon), Sanofi Group (Genzyme), B. Braun Melsungen AG, Atrium Medical Corporation (Atrium Biosurgery), Stryker Corporation, Hemostasis, LLC, Medtronic plc, and Kuros Biosciences AG.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

 

Capsule Endoscopy Market: Opportunities and Forecasts, 2016 – 2024

Global Capsule Endoscopy Market: Overview

Capsule endoscopy is a painless, minimally invasive procedure used for the detection of digestive disorders. In capsule endoscopy, a pill-sized endoscope is swallowed by the patient and images of the digestive tract are recorded and later examined for the diagnosis of various intestinal diseases. Capsule endoscopies are performed to detect Crohn’s disease, celiac disease, obscure gastrointestinal bleeding, tumors in the small intestine, adverse reactions to nonsteroidal anti-inflammatory drugs (NSAID), and various other conditions that inflict the digestive system. Various types of capsule endoscopes are used to examine the small bowel, esophagus, and colon. The primary components of capsule endoscopes are a camera, a transmitter, batteries, and a light source.

Obtain Report Details: http://www.transparencymarketresearch.com/capsule-endoscopes-market.html

One of the key factors driving the capsule endoscopy market is the rising incidence of gastrointestinal diseases. According to the National Institutes of Health, around 60 to 70 million Americans are affected by gastrointestinal diseases each year. In 2004 alone, an estimated 236,000 deaths, 72 million ambulatory care visits, and 4.6 million hospitalizations were attributed to gastrointestinal diseases in the U.S., with the healthcare expenditure on these diseases pegged at around US$142 bn each year.

Global Capsule Endoscopy Market: Key Trends and Opportunities

The global market for capsule endoscopy has been witnessing a steady rise in demand owing to a number of factors, including the presence of supportive government initiatives, the demand for more accurate and faster diagnostic tools, the rise in the global geriatric population, and the introduction of technologically advanced devices such as endoscopes with a longer battery life, Wi-Fi-enabled capsules, and magnetic and hybrid versions.

The demand for small bowel capsules has been consistent owing to their rising usage for the detection of medical conditions such as inflammatory bowel disease, small bowel neoplastic lesions, obscure gastrointestinal tract bleeding, and Crohn’s disease. The demand for colon capsules is also anticipated to witness a rise in the coming years owing to the increasing prevalence of colon cancer. The demand for less invasive diagnostic procedures in such cases is likely to push the market for colon capsule endoscopy.

Global Capsule Endoscopy Market: Regional Outlook

There are four main geographical segments of the global capsule endoscopy market: Europe, North America, Asia Pacific, and Rest of the World. North America is the clear leader in the overall capsule endoscopy market and is likely to retain its lead position through the forecast period. The increasing prevalence of colorectal cancer and gastrointestinal disorders is one of the key factors fueling this market. Other major drivers include the presence of favorable reimbursement policies, the availability of advanced healthcare infrastructure, and the rising adoption of minimally invasive endoscopy procedures.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12683

The Asia Pacific capsule endoscopy market is projected to witness impressive growth in the near future owing to a surge in patient awareness levels, the rise in disposable income and healthcare spending, improving healthcare infrastructure, the presence of untapped opportunities in the area of cancer screening, and the establishment of several endoscopic training centers. A number of countries in the Middle East, North Africa, and South America are also anticipated to experience steady growth owing to the presence of an efficient workforce, rising investments in personnel training, and numerous government initiatives.

There are a number of players competing in the global capsule endoscopy market, the prominent ones being Fujifilm Holding Corporation, Olympus Corporation, RF System Lab, Chongqing Jinshan Science & Technology Co., Capso Vision Inc., IntroMedic Co., Ltd., and Given Imaging Ltd. These companies have been adopting several business strategies, such as new product development and research activities to withstand the intensifying competition in the capsule endoscopy market.

 

Pharmaceutical Excipients Market: Impact of Key Factors Influencing the Parent Industry

With the pharmaceuticals market comfortably poised to reach annual revenues of US$400 bn before the end of 2020 (according to the World Health Organization), the demand for excipients is expected to exhibit steady growth. This report creates a holistic perspective of the current dynamics that govern the global pharmaceutical excipients market. How the tightening grip of regulators over the excipients used in the market will impact manufacturers and vendors is also assessed. Analysts have also evaluated the projected impact of disruptive drug delivery techniques on those in the business of pharmaceutical excipients.

A pharmaceutical excipient is a substance-either natural or synthetically formulated-that serves multiple purposes in a medicines and drugs. It is used as a bulking or stabilizing substance, as an agent to enhance the solubility of a drug, or as an ingredient that enhances the therapeutic effect of a drug.

Obtain Report Details: http://www.transparencymarketresearch.com/pharmaceutical-excipients-market.html

There are also some excipients that may lend more value during the manufacturing or handling process of a drug or medicine. Excipients are also used in applications where the in-vitro integrity and stability of drugs need to be preserved. The type and volume of excipient added to a pharmaceutical formulation depends largely on whether the drug is to be administered orally or intravenously. Since certain excipients may effect an undesirable chemical reaction when used alongside an active ingredient or in a certain environment, the selection of the excipient needs to be made carefully.

Global Pharmaceutical Excipients Market: Drivers, Restraints and Trends

Although excipients are used in chemicals and food and beverage sector as well, their use is very closely regulated in the pharmaceutical sector. This puts considerable pressure on manufacturers of pharmaceutical excipients who have to follow numerous process-related and regulatory procedures to bring their products to the market. Besides this factor, a slight but steady decline in the investment inflow in pharmaceutical R&D projects could act against the growth of the global pharmaceutical excipients market.

While these two restraints remain a major concern, the scenario is anything but gloomy for companies operating in the global pharmaceutical excipients market. As companies strive to improve the efficacy and delivery of drugs, new opportunities are bound to emerge even in the pharma excipients space. For instance, the rising interest in nanotechnology in drug delivery and endeavors to reduce the toxicity of drugs are initiatives that will pave the way for the use of innovative excipients.

Opportunities in the global pharmaceutical excipients market are primarily centered on the growing scientific understanding of functionality excipients.

Global Pharmaceutical Excipients Market: Segmentation

If broadly classified according to type, the global market for pharmaceutical excipients can be segmented into organic and inorganic. Carbohydrates and petrochemicals are the two main classes of organic excipients. Inorganic excipients include such substances as metal oxides, calcium carbonates, calcium phosphates, and halites.

Excipients can be used in different types of drug formulation, including but not limited to: oral formulation such as capsules and tablets, parenteral drugs, topical application drugs, and advanced drug delivery systems. The use of excipients in oral drug administration has traditionally been the highest and continues to stay so. Topical drugs are infusing new growth into the global pharmaceutical excipients market.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12662

Based on functionality, pharmaceutical excipients serve as flavoring agents, binders, coatings, preservatives, viscosity agents, lubricants, and more.

Global Pharmaceutical Excipients Market: Region-wise Outlook

Europe has a sizeable pharmaceuticals excipients market, which is also among the largest in the world. North America follows Europe in terms of the size of the excipients market. Globally, Asia Pacific is yet another sizeable pharmaceutical excipients market.

Organizations such as the International Pharmaceutical Excipient Councils function on the global and regional level to promote the proper and safe usage of pharma excipients. Among the key companies operating in the global pharmaceutical excipients market are: BASF SE, Evonik Industries AG, Ashland, Inc., Archer Daniels Midland Company, Croda International Plc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

 

Ebola Drug and Vaccine Market – Emerging Growth Factors and Forecasts 2024

The rising threat of a global Ebola pandemic is the major driver for the global Ebola drug and vaccines market, according to a new report from Transparency Market Research. The report, titled ‘Ebola Drug and Vaccine Market – Global Industry Analysis, Size, Share, Growth, Trends & Forecasts 2016 – 2024,’ presents a solid outline of the historical development of the market, in addition to comprehensive information about the market’s present condition. TMR analysts have further presented reliable predictions regarding the market’s development in the coming years based on insights into the market’s development pattern.

Ebola is a viral disease causing both external and internal bleeding, fever, muscular pain, headaches, vomiting, and notable impairment of liver and kidney functions. Like many viral diseases, Ebola can spread through direct contact with the body fluids of an affected human or animal. The Ebola drug and vaccines market came into the global spotlight after the epidemic in West Africa in late 2013. Since then, governments in many countries where Ebola has spread have taken steps to fund extensive research into treating the disease. Continued government support is crucial for the Ebola drug and vaccines market in the coming years.

Obtain Report Details: http://www.transparencymarketresearch.com/ebola-drug-and-vaccine-market.html

The lack of an effective cure for Ebola has driven investment into the field, with the unknown variables about the Ebola virus necessitating extensive research to come up with treatments and disease management plans. This has also made research into Ebola drugs and vaccines financially lucrative for healthcare industry players due to the possibility of coming up with different containment and management solutions targeted at different aspects of the disease.

The government support to the Ebola drug and vaccines market has been amplified by the spread of the disease to the developed world. This has brought the matter to the attention of the much better equipped healthcare sector in the developed world, where long-term research into Ebola therapeutics is economically feasible. This has notably boosted research into the etiology and treatment of the disease in recent years. The prevailing risk of further outbreaks due to the increasing ease of getting in and out of the region where Ebola originated is likely to ensure steady funding for research into Ebola drugs and vaccines in the coming years.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12476

Geographically, North America is the leading contributor to the global Ebola drug and vaccines market. The advanced healthcare research scenario in North America is responsible for the leading share of the regional segment, with U.S. healthcare industry players having among the most comprehensive operations in the field of Ebola research.

The key companies in the global Ebola drug and vaccines market are Serepata Therapeutics, NewLink Genetics Corp., Tekmira Pharmaceuticals, BioCryst Pharmaceutical Inc., and Mapp Biopharmaceutical. The report presents detailed information about the market operations of these companies in order to derive vital insights into the competitive landscape of the Ebola drug and vaccines market.